Physician profile
Theodore M Teacher
NPI 1871514729
$6,531.82
in general payments reported to CMS, 2019-2025
40 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $1,150 · 2021: $1,259 · 2022: $687 · 2023: $864 · 2024: $1,115 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,091 · Education: $1.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,091.35 |
| Education | $1.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,313.56 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Biogen, INC. | $500.84 | 2019-2025 | Vumerity, Leqembi, Avonex |
| Lilly USA, LLC | $477.54 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Ucb, INC. | $409.90 | 2019-2025 | Rystiggo, Briviact |
| Supernus Pharmaceuticals, INC. | $395.46 | 2019-2020 | |
| Sk Life Science, INC. | $326.88 | 2020-2025 | Xcopri |
| Allergan, INC. | $276.17 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $267.34 | 2019-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $225.41 | 2019-2025 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $218.37 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $192.00 | 2022-2025 | Crexont, Rytary |
| Emd Serono, INC. | $183.83 | 2021-2025 | |
| Genzyme Corporation | $179.29 | 2019-2022 | |
| Lundbeck LLC | $159.67 | 2023-2025 | Rexulti, Vyepti |
| Amgen INC. | $144.68 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Teacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.